SCN1A and Alzheimer disease: Intriguingly, many of the kinases and associated signaling proteins linked with AD pathology are regulators of Nav1.1 or Nav1.6 and exert their functional effects via post-translational modifications (PTMs) and/or direct binding to the channel (Table 1) [92].